RYR2 and autoimmune disease: The therapeutic effects that RyR2-deficient Tconvs conveyed in multiple inflammatory and autoimmune models suggest that targeting of RyR2 activity may have therapeutic potential for autoimmune diseases, which are often associated with low numbers or dysfunction of Tregs (3, 13, 14).